Table 2. Incidence (per 1000 person-years) of hematologic disorders (anemia or hematologic malignancy) among ADT, RT, and RP groups.
| Incidence (per 1000 person-years) | ADT v.s. RP | RT v.s. RP | |||||
|---|---|---|---|---|---|---|---|
| Outcome | ADT (n = 1,797) |
RT (n = 1797) |
RP (n = 1797) |
Adjusted HR (95% CI) |
P-value | Adjusted HR (95% CI) |
P-value |
| Hematologic disorders | 28.18 | 36.01 | 17.07 | 1.60 (1.29–1.97) | <0.001** | 1.98 (1.62–2.42) | <0.001** |
| Anemia | 27.20 | 33.08 | 16.05 | 1.63 (1.31–2.02) | <0.001** | 1.92 (1.56–2.37) | <0.001** |
| Hematologic malignancy | 1.93 | 3.96 | 1.80 | 1.12 (0.53–2.37) | 0.760 | 2.48 (1.29–4.76) | 0.006* |
Abbreviations: ADT, androgen deprivation therapy; RT, radiotherapy; RP, radical prostatectomy; HR, hazard ratio; CI, confidence interval
*P <0.05
**P <0.001